Table 6.
Distribution of detailed CVD types in the context of SARS-Cov-test and sex.
| Overall distribution (regardless of sex) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Class | SARS-Cov-2: negative | SARS-Cov-2: positive | SARS-Cov-2: negative | SARS-Cov-2: positive | No stratification corrections | Generalized CMH (adjusted for stratification by sex) | ||||||||
| Count (n) | Count (n) | Frequency (%) | Frequency (%) | χ2 | p | OR | OR {− 95% CI} | OR {95% CI} | χ2 | p | OR | OR {− 95% CI} | OR {95% CI} | ||
| ACS: type | NSTEMI | 274 (280.51) | 30 (23.49) | 34.77 | 45.45 | 3.10 | 0.2120 | – | – | – | 3.67 | 0.1575 | – | – | – |
| STEMI | 410 (404.15) | 28 (33.85) | 52.03 | 42.42 | |||||||||||
| Unstable angina | 104 (103.34) | 8 (8.66) | 13.20 | 12.12 | |||||||||||
| ACS: heart failure | Symptoms present | 116 (126.2) | 21 (10.8) | 15.76 | 33.33 | 12.61 | 0.0004 | 2.672 | 1.526 | 4.679 | 12.96 | 0.0003 | 2.708 | 1.546 | 4.743 |
| No symptoms | 620 (609.8) | 42 (52.2) | 84.24 | 66.67 | |||||||||||
| Arrhythmia: type | Atrial | 145 (144.75) | 13 (13.25) | 49.15 | 48.15 | 0.08 | 0.7757 | – | – | – | 3.20 | 0.2016 | – | – | – |
| Ventricular | 41 (43.98) | 7 (4.02) | 13.90 | 25.93 | |||||||||||
| Heart block, bradycardia | 109 (106.27) | 7 (9.73) | 36.95 | 25.93 | |||||||||||
| Arrhythmia: heart failure | Symptoms present | 75 (73.98) | 4 (5.02) | 28.30 | 22.22 | 0.31 | 0.5779 | – | – | – | 0.28 | 0.5949 | – | – | – |
| No symptoms | 190 (191.02) | 14 (12.98) | 71.70 | 77.78 | |||||||||||
| PE: heart failure | Symptoms present | 9 (7.43) | 2 (3.57) | 36.00 | 16.67 | 0.67 | 0.4121 | – | – | – | 1.40 | 0.2368 | – | – | – |
| No symptoms | 16 (17.57) | 10 (8.43) | 64.00 | 83.33 | |||||||||||
| AHF: type | CHF decompensation | 95 (95.78) | 10 (9.22) | 70.37 | 76.92 | 0.031 | 0.8594 | – | – | – | 0.40 | 0.5267 | – | – | – |
| De novo | 40 (39.22) | 3 (3.78) | 29.63 | 23.08 | |||||||||||
| Subset distribution (sex: female) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Class | SARS-Cov-2: negative | SARS-Cov-2: positive | SARS-Cov-2: negative | SARS-Cov-2: positive | χ2 | p | OR | OR {− 95% CI} | OR {95% CI} | |||||
| Count (n) | Count (n) | Frequency (%) | Frequency (%) | ||||||||||||
| ACS: type | NSTEMI | 106 (105.73) | 6 (6.27) | 41.90 | 40.00 | 0.88 | 0.6427 | – | – | – | |||||
| STEMI | 111 (112.34) | 8 (6.66) | 43.87 | 53.33 | |||||||||||
| Unstable angina | 36 (34.93) | 1 (2.07) | 14.23 | 6.67 | |||||||||||
| ACS: heart failure | Symptoms present | 42 (42.42) | 3 (2.58) | 18.26 | 21.43 | 0.00 | 0.9536 | 1.221 | 0.326 | 4.569 | |||||
| No symptoms | 188 (187.58) | 11 (11.42) | 81.74 | 78.57 | |||||||||||
| Arrhythmia: type | Atrial | 81 (80.76) | 7 (7.24) | 55.86 | 53.85 | 5.40 | 0.0672 | – | – | – | |||||
| Ventricular | 15 (17.44) | 4 (1.56) | 10.34 | 30.77 | |||||||||||
| Heart block, bradycardia | 49 (46.8) | 2 (4.2) | 33.79 | 15.38 | |||||||||||
| Arrhythmia: heart failure | Symptoms present | 28 (26.13) | 0 (1.87) | 22.22 | 0.00 | 1.35 | 0.2448 | – | – | – | |||||
| No symptoms | 98 (99.87) | 9 (7.13) | 77.78 | 100.00 | |||||||||||
| PE: heart failure | Symptoms present | 5 (4.0) | 1 (2.0) | 41.67 | 16.67 | 0.28 | 0.5959 | – | – | – | |||||
| No symptoms | 7 (8.0) | 5 (4.0) | 58.33 | 83.33 | |||||||||||
| AHF: type | CHF decompensation | 32 (31.5) | 4 (4.5) | 65.31 | 57.14 | < 0.00001 | 1.0000 | – | – | – | |||||
| De novo | 17 (17.5) | 3 (2.5) | 34.69 | 42.86 | |||||||||||
| Subset distribution (sex: male) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Class | SARS-Cov-2: negative | SARS-Cov-2: positive | SARS-Cov-2: negative | SARS-Cov-2: positive | χ2 | p | OR | OR {− 95% CI} | OR {95% CI} | |||||
| Count [n] | Count [n] | Frequency [%] | Frequency [%] | ||||||||||||
| ACS: type | NSTEMI | 168 (175.29) | 24 (16.71) | 31.40 | 47.06 | 5.90 | 0.0524 | – | – | – | |||||
| STEMI | 299 (291.24) | 20 (27.76) | 55.89 | 39.22 | |||||||||||
| Unstable angina | 68 (68.47) | 7 (6.53) | 12.71 | 13.73 | |||||||||||
| ACS: heart failure | Symptoms present | 74 (83.88) | 18 (8.12) | 14.62 | 36.73 | 15.79 | 0.0001 | 3.390 | 1.804 | 6.371 | |||||
| No symptoms | 432 (422.12) | 31 (40.88) | 85.38 | 63.27 | |||||||||||
| Arrhythmia: type | Atrial | 64 (64.02) | 6 (5.98) | 42.67 | 42.86 | 0.18 | 0.9135 | – | – | – | |||||
| Ventricular | 26 (26.52) | 3 (2.48) | 17.33 | 21.43 | |||||||||||
| Heart block, bradycardia | 60 (59.45) | 5 (5.55) | 40.00 | 35.71 | |||||||||||
| Arrhythmia: heart failure | Symptoms present | 47 (47.9) | 4 (3.1) | 33.81 | 44.44 | 0.083 | 0.7729 | – | – | – | |||||
| No symptoms | 92 (91.1) | 5 (5.9) | 66.19 | 55.56 | |||||||||||
| PE: heart failure | Symptoms present | 4 (3.42) | 1 (1.58) | 30.77 | 16.67 | 0.0078 | 0.9245 | – | – | – | |||||
| No symptoms | 9 (9.58) | 5 (4.42) | 69.23 | 83.33 | |||||||||||
| AHF: type | CHF decompensation | 63 (64.5) | 6 (4.5) | 73.26 | 100.00 | 0.95 | 0.3295 | – | – | – | |||||
| De novo | 23 (21.5) | 0 (1.5) | 26.74 | 0.00 | |||||||||||
Numbers in ‘()’ brackets indicate expected (estimated) counts. Significant odds ratios (ORs) are marked in bold.